Insiders Trades
Oxurion Stock: price and insider trades · Belgium
No insider purchase over the last 90 days. The latest was filed 10 Mar 2022.
Oxurion: what insiders have been doing
Oxurion is a listed company. Its directors and officers file their transactions with FSMA. The past year has been quiet: not a single insider filing for Oxurion. The previous disclosure was published on 10 March 2022.
Source: insider filings from FSMA. Past trades are no guide to future returns.
Insider Decl.
3
Thresholds
n/a
Buy Volume
€3M
2 ops. · all time
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended December 2025 · cache
€0.00
Analyst consensus
Income statement
Revenue€555k
Gross profit€555k100% margin
EBITDA-€3.6M-652% margin
Net income-€3.7M-671.7% margin
Valuation
Beta-0.11
Balance sheet & cash
Market cap€366k
Total debt€11.4M
Free Cash Flow-€1.7M
Profitability & ownership
ROA-43.2%
% insiders21.1%
% institutions0.0%
Last declaration on 10 March 2022
Declarations3 total
1,180,555 shares@ €1.44100.0% of flowShareOff exchangeISIN BE0003846632FSMA:oxurion-1
Canonical exit: 5 Jun 2022 (T+90)
1,180,555 shares@ €1.44100.0% of flowShareOff exchangeISIN BE0003846632FSMA:oxurion
Canonical exit: 5 Jun 2022 (T+90)
2,766,337 shares@ €2.03100.0% of flowShareOff exchangeISIN BE0003846632FSMA:oxurion-0
3 of 3 declarations
About Oxurion
Oxurion is a Belgian biopharmaceutical company focused on developing treatments for eye diseases. It aims to provide innovative therapies to improve patients' vision.
